Phacilitate Leaders World

Sponsors & Exhibitors

Sponsors & Exhibitors

Loading
  • Letter
    • L
  • L7's mission is to revolutionize scientific process and data management in order to accelerate discoveries and drive a higher quality of healthcare. Our end-to-end solutions and services yield efficie ...
  • Life Changing Events

    Stand: WSC21
    Life Changing Events is a marketing company that assists doctors and practices acquire more cash paying clients through a proprietary system that maximizes ROI while minimizing risk. We have assembled ...
  • Longeveron

    Stand: WSC10
    A Regenerative Medicine and Cellular Therapy Manufacturing Company Longeveron LLC was founded to provide cell therapeutics for unmet medical needs.  The company’s lead product, Longeveron Mesenchymal ...
  • At Lonza Pharma & Biotech we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need.  From the building blocks of life ...
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK